Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by White, N. H.
Right arrow Articles by Santiago, J. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by White, N. H.
Right arrow Articles by Santiago, J. V.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 34, Issue 9 870-875, Copyright © 1985 by American Diabetes Association


ARTICLES

Plasma pancreatic polypeptide response to insulin-induced hypoglycemia as a marker for defective glucose counterregulation in insulin-dependent diabetes mellitus

NH White, RL Gingerich, LA Levandoski, PE Cryer and JV Santiago

Defective glucose counterregulation occurs in some insulin-dependent diabetic subjects (IDDMs) as a result of a combined deficiency of glucagon (IRG) and epinephrine (EPI) secretion in response to insulin-induced hypoglycemia. To determine whether the deficient glucagon response, the deficient epinephrine response, or both are manifestations of autonomic dysfunction, we used the pancreatic polypeptide (PP) secretory response to insulin-induced hypoglycemia as a marker for autonomic neuropathy. Seven nondiabetic controls and 21 IDDMs were given insulin at 40 mU/kg/h after overnight euglycemia. Eight of the IDDMs had defective counterregulation (-CR), and 13 had adequate counterregulation (+CR) by our previously published criteria. Those with -CR had a blunted EPI (delta EPI = 102 +/- 16 pg/ml; mean +/- SEM) and PP (delta PP = 12 +/- 13 pg/ml) response as compared with controls (delta EPI = 310 +/- 49; delta PP = 498 +/- 43) and IDDMs with +CR (delta EPI = 291 +/- 32; delta PP = 521 +/- 86). In controls, IRG rose by 31 +/- 6 pg/ml; in IDDMs, IRG failed to rise significantly above baseline regardless of counterregulatory status. Although the PP and EPI responses correlated well (r = 0.626, P less than 0.001), the IRG response failed to correlate with either the EPI or the PP response. We conclude that the deficient epinephrine, but not glucagon, secretory response to hypoglycemia in diabetic subjects is a result of autonomic neuropathy.(ABSTRACT TRUNCATED AT 250 WORDS)
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
M. R. Rickels, M. H. Schutta, R. Mueller, J. F. Markmann, C. F. Barker, A. Naji, and K. L. Teff
Islet Cell Hormonal Responses to Hypoglycemia After Human Islet Transplantation for Type 1 Diabetes
Diabetes, November 1, 2005; 54(11): 3205 - 3211.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child.Home page
L A Ross, R E Warren, C J H Kelnar, and B M Frier
Pubertal stage and hypoglycaemia counterregulation in type 1 diabetes
Arch. Dis. Child., February 1, 2005; 90(2): 190 - 194.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
P. Galassetti, D. Tate, R. A. Neill, S. Morrey, D. H. Wasserman, and S. N. Davis
Effect of sex on counterregulatory responses to exercise after antecedent hypoglycemia in type 1 diabetes
Am J Physiol Endocrinol Metab, July 1, 2004; 287(1): E16 - E24.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
P. Galassetti, D. Tate, R. A. Neill, S. Morrey, D. H. Wasserman, and S. N. Davis
Effect of Antecedent Hypoglycemia on Counterregulatory Responses to Subsequent Euglycemic Exercise in Type 1 Diabetes
Diabetes, July 1, 2003; 52(7): 1761 - 1769.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
M. W. Steffes, S. Sibley, M. Jackson, and W. Thomas
{beta}-Cell Function and the Development of Diabetes-Related Complications in the Diabetes Control and Complications Trial
Diabetes Care, March 1, 2003; 26(3): 832 - 836.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
P. Galassetti, D. Tate, R. A. Neill, S. Morrey, and S. N. Davis
Effect of Gender on Counterregulatory Responses to Euglycemic Exercise in Type 1 Diabetes
J. Clin. Endocrinol. Metab., November 1, 2002; 87(11): 5144 - 5150.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1985 by the American Diabetes Association.